OTCMKTS:HMDEF DionyMed Brands (HMDEF) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HMDEF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume118,200 shsAverage Volume56,544 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get DionyMed Brands alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About DionyMed BrandsDionyMed Brands Inc., a cannabis brand and distribution platform, designs, develops, manufactures, processes, markets, distributes, and sells a portfolio of branded cannabis products in the United Stated. The company offers various products, including flowers, vape cartridges, concentrates, edible confections, pre-polls, and vape pens, as well as cannabidiol and tetrahydrocannabinol distillates. It also provides value-added manufacturing and distribution services, such as distribution, fulfillment, warehousing, and inventory management services, as well as logistic services for cultivators, manufacturers, and third party brands. In addition, the company offers co-packing services comprising manicuring, packaging, and labeling dry bulk-flower from cultivators, as well as filling and packaging vape cartridges and other concentrates. It serves the medical and adult-use cannabis markets. The company sells its products online and through retail dispensaries, as well as direct-to-consumers. DionyMed Brands Inc. was founded in 2017 and is headquartered in Vancouver, Canada.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> HMDEF Stock News HeadlinesDecember 19, 2023 | bbc.comRobot cracks open safe live on Def Con's stageOctober 12, 2023 | foxnews.comPolice probe Russell Brand sex assault allegations as red flags emerge from comedian's pastApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.September 28, 2023 | nypost.comRussell Brand: Big Tech plays judge, jury and executioner before a trial againJune 7, 2023 | forbes.comYour Employer Brand Owns The Candidate ExperienceApril 7, 2023 | forbes.comWhy You Should Build A Brand, Not Just A BusinessOctober 14, 2022 | forbes.comBest Air Conditioning Brands Of 2022See More Headlines Receive HMDEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DionyMed Brands and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:HMDEF CUSIPN/A CIKN/A Webwww.dionymed.com PhoneN/AFaxN/AEmployees121Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Edward M. FieldsChairman & CEOEvan TenenbaumPresMr. Peter Kampian C.A. (Age 60)CPA, CPA, CA, Chief Financial Officer Mr. Peter E. Hilliard (Age 52)Chief Operating Officer Ms. Michelle SittonChief Marketing OfficerKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors This page (OTCMKTS:HMDEF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DionyMed Brands Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
